The Peter Attia Drive

Podbit · The Peter Attia Drive

#395 - Brain lipidology: understanding APOE, cholesterol homeostasis, Alzheimer's disease risk, and the effects of lipid-lowering therapies on brain health | Tom Dayspring, M.D.

Explore episode Jun 8, 2026
Science
Desmosterol: The Blood Test That Reflects Brain Cholesterol Synthesis

#395 - Brain lipidology: understanding APOE, cholesterol ho… · Jun 8, 2026 Science

Astrocytes synthesize cholesterol via the desmosterol pathway, and plasma desmosterol correlates strongly with CSF desmosterol and brain cholesterol production. Studies show low plasma desmosterol is associated with higher rates of cognitive impairment — making it a clinically measurable proxy for brain cholesterol health.

Where this was said

Neurons, desmosterol, and cholesterol synthesis in the brain

At 44:50 · chapter starts 41:45

Peter asks about the two cholesterol synthesis pathways that share a common trunk before bifurcating at their penultimate sterol. Tom explains that in peripheral tissues, the lathosterol pathway dominates; in the brain, it is the desmosterol pathway — used by astrocytes — that is predominant. When neurons are young and actively synthesizing cholesterol, they use the lathosterol pathway; after age 10, when neurons stop making cholesterol, lathosterol production in the brain essentially ceases. Desmosterol, by contrast, continues to be produced by astrocytes throughout life and reflects ongoing brain cholesterol synthesis. The remarkable clinical implication: plasma desmosterol correlates highly with cerebrospinal fluid desmosterol, meaning a routine blood test can serve as a window into the brain's cholesterol factory. A study using mass spectrometry found that people with low desmosterol have higher rates of cognitive impairment and Alzheimer's disease. Tom also notes that desmosterol is commercially measurable, unlike 24S-hydroxycholesterol, which remains confined to research settings — though both are valuable biomarkers of brain cholesterol health.

Similar podbits

Science
The Placebo Effect Is Not Fake — It Just Belongs to the Story, Not the Drug

#403 ‒ Peptides: separating scientific promise from marketi… · Aug 10, 2026 Science

Peptides come loaded with a powerful narrative: regenerative, subcutaneous, targeted, cutting-edge. That narrative can genuinely move outcomes, especially for pain, energy, and recovery. The RCT's job is to quantify how much additional benefit comes from the molecule itself — above and beyond the compelling story surrounding it.